RetinalGenix Technologies (RTGN) Other Accumulated Expenses (2021 - 2026)

RetinalGenix Technologies has disclosed Other Accumulated Expenses across 6 years of filings, most recently posting $468428.0 for Q1 2026.

• Other Accumulated Expenses for Q1 2026 came in at $468428.0, up 164.65% year-over-year; the trailing twelve-month figure through Mar 2026 was $468428.0 (up 164.65% YoY), and the FY2025 annual result was $674842.0, up 4195.89% from the prior year.
• Other Accumulated Expenses came in at $468428.0 for Q1 2026 at RetinalGenix Technologies, down from $674842.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $811176.0 in Q2 2023 to a low of $901.0 in Q3 2023.
• The 5-year median for Other Accumulated Expenses is $430309.0 (2024), against an average of $385842.3.
• Across the five-year window, Other Accumulated Expenses tumbled 99.84% in 2023 and soared 56427.08% in 2024, its largest moves.
• RetinalGenix Technologies' Other Accumulated Expenses stood at $427933.0 in 2022, then slumped by 99.36% to $2760.0 in 2023, then soared by 469.17% to $15709.0 in 2024, then jumped by 4195.89% to $674842.0 in 2025, then plunged by 30.59% to $468428.0 in 2026.
• The last three Other Accumulated Expenses figures came in at $468428.0 (Q1 2026), $674842.0 (Q4 2025), and $539052.0 (Q3 2025), per Business Quant data.